Literature DB >> 33822119

Rotavirus Genotype Trends and Gastrointestinal Pathogen Detection in the United States, 2014-2016: Results From the New Vaccine Surveillance Network.

Mathew D Esona1, M Leanne Ward1, Mary E Wikswo1, Slavica M Rustempasic1, Rashi Gautam1, Charity Perkins1, Rangaraj Selvarangan2, Christopher J Harrison2, Julie A Boom3, Janet A Englund4, Eileen J Klein4, Mary Allen Staat5, Monica M McNeal5, Natasha Halasa6, James Chappell6, Geoffrey A Weinberg7, Daniel C Payne1, Umesh D Parashar1, Michael D Bowen1.   

Abstract

BACKGROUND: Following the implementation of rotavirus vaccination in 2006, severe acute gastroenteritis (AGE) due to group A rotavirus (RVA) has substantially declined in US children. We report the RVA genotype prevalence as well as coinfection data from 7 US New Vaccine Surveillance Network sites during 3 consecutive RVA seasons, 2014-2016.
METHODS: A total of 1041 stool samples that tested positive for RVA by Rotaclone enzyme immunoassay were submitted to the Centers for Disease Control and Prevention (CDC) for RVA genotyping and multipathogen testing.
RESULTS: A total of 795 (76%) samples contained detectable RVA when tested at the CDC. Rotavirus disease was highest in children < 3 years of age. Four G types (G1, G2, G9, and G12) accounted for 94.6% of strains while 2 P types (P[4] and P[8]) accounted for 94.7% of the strains. Overall, G12P[8] was the most common genotype detected in all 3 seasons. Stepwise conditional logistic analysis found year and study site were significant predictors of genotype. Twenty-four percent of RVA-positive specimens contained other AGE pathogens.
CONCLUSIONS: G12P[8] predominated over 3 seasons, but strain predominance varied by year and study site. Ongoing surveillance provides continuous tracking and monitoring of US genotypes during the postvaccine era. Published by Oxford University Press for the Infectious Diseases Society of America 2021.

Entities:  

Keywords:  NVSN; US; gastrointestinal pathogen; genotyping; rotavirus

Mesh:

Substances:

Year:  2021        PMID: 33822119     DOI: 10.1093/infdis/jiab177

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Comparative genomic analysis of genogroup 1 and genogroup 2 rotaviruses circulating in seven US cities, 2014-2016.

Authors:  Mathew D Esona; Rashi Gautam; Eric Katz; Jose Jaime; M Leanne Ward; Mary E Wikswo; Naga S Betrapally; Slavica M Rustempasic; Rangaraj Selvarangan; Christopher J Harrison; Julie A Boom; Jan Englund; Eileen J Klein; Mary Allen Staat; Monica M McNeal; Natasha Halasa; James Chappell; Geoffrey A Weinberg; Daniel C Payne; Umesh D Parashar; Michael D Bowen
Journal:  Virus Evol       Date:  2021-03-12

2.  Diversity of rotavirus strains circulating in Haiti before and after introduction of monovalent vaccine.

Authors:  Mentor Ali Ber Lucien; Mathew D Esona; Manise Pierre; Gerard Joseph; Chedelène Rivière; Eyal Leshem; Negar Aliabadi; Anne Marie Desormeaux; Jocelyn Andre-Alboth; David L Fitter; Yoran Grant-Greene; Jacqueline Tate; Jacques Boncy; Roopal Patel; Eleanor Burnett; Stanley Juin; Umesh D Parashar; Michael D Bowen
Journal:  IJID Reg       Date:  2022-07-14

Review 3.  Rotavirus Strain Trends in United States, 2009-2016: Results from the National Rotavirus Strain Surveillance System (NRSSS).

Authors:  Slavica Mijatovic-Rustempasic; Jose Jaimes; Charity Perkins; M Leanne Ward; Mathew D Esona; Rashi Gautam; Jamie Lewis; Michele Sturgeon; Junaid Panjwani; Gail A Bloom; Steve Miller; Erik Reisdorf; Ann Marie Riley; Morgan A Pence; James Dunn; Rangaraj Selvarangan; Robert C Jerris; Dona DeGroat; Umesh D Parashar; Margaret M Cortese; Michael D Bowen
Journal:  Viruses       Date:  2022-08-15       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.